Vanda Pharmaceuticals | VNDA - Current Assets

Stock Price
7.44
Daily Change
0.02 0.27%
Monthly
0.40%
Yearly
56.63%
Q1 Forecast
4.24

Vanda Pharmaceuticals reported $367.5M in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
Acadia Pharmaceuticals USD 1.08B 115.87M Sep/2025
Agios Pharmaceuticals USD 1.03B 13.64M Sep/2025
Akebia Therapeutics USD 258.34M 23.68M Sep/2025
Alnylam Pharmaceuticals USD 3.95B 309.11M Sep/2025
Anika Therapeutics USD 101.59M 2.27M Sep/2025
Arrowhead Research USD 1.17B 223.75M Dec/2025
AstraZeneca USD 28.72B 1.22B Dec/2025
Bristol-Myers Squibb USD 35.63B 2.41B Sep/2025
Eli Lilly USD 62.07B 12.22B Sep/2025
Enanta Pharmaceuticals USD 198.68M 5.65M Dec/2025
Esperion Therapeutics USD 360.46M 17.87M Sep/2025
Halozyme Therapeutics USD 1.33B 206.08M Sep/2025
Heron Therapeutics USD 229.4M 18.48M Sep/2025
Insmed USD 1.93B 149.77M Sep/2025
J&J USD 55.62B 1.01B Dec/2025
Lexicon Pharmaceuticals USD 145.08M 100.72M Jun/2025
Ligand Pharmaceuticals USD 753.92M 400.98M Sep/2025
Merck USD 47.56B 10.49B Sep/2025
Minerva Neurosciences USD 13.02M 2.53M Sep/2025
Moderna USD 6.6B 427M Sep/2025
Novartis USD 28.2B 2.26B Sep/2025
Pfizer USD 46.92B 3.22B Sep/2025
PTC Therapeutics USD 2.01B 265.07M Sep/2025
Puma Biotechnology USD 143.58M 7M Sep/2025
Sangamo BioSciences USD 49.89M 12.3M Jun/2025
Sanofi EUR 30.95B 3.09B Dec/2025
Takeda JPY 3.12T 195.82B Dec/2025
Teva Pharmaceutical Industries USD 13.95B 1.21B Dec/2025
Ultragenyx Pharmaceutical USD 643.21M 76.58M Sep/2025
Vanda Pharmaceuticals USD 367.5M 27.42M Sep/2025
Veracyte USD 449.22M 34.54M Sep/2025